Cholesterol Conversations How Do We Get There from Here: Partnering with Patients to Achieve LDL Goals
Mar 8, 2023
Drs. Marc Bonaca, Pam Taub, and Heather Johnson talk about multiagent therapy for cholesterol treatment and the efficacy of novel agents. They emphasize the importance of shared decision-making, managing high-risk populations, and simplifying prior authorization. They also discuss the benefits of a team approach in lipid management and the potential of non-statin options like Bempedoic acid.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 3min
Bempedoic Acid: A Promising Non-Statin Option for Cholesterol Treatment
03:07 • 6min
Understanding Statin Intolerance and the Importance of Shared Decision Making
09:02 • 2min
Simplifying Prior Authorization for Cholesterol Treatment
11:17 • 5min
Utilizing a Team Approach for Lipid Management and the Significance of the Clear Outcomes Trial
16:11 • 3min